✦ LIBER ✦

Low-dose, non-toxic IL-2 therapy is effective in the treatment of HIV/HBV and HIV/HCV coinfection

✍ Scribed by Schlaak, J.F.; Radecke, K.; Meyer zum Büschenfelde, K.-H.; Gerken, G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose, non-toxic IL-2 as therapy for

✍ J.F. Schlaak; K. Radecke; W. Kaluza; K.-H. Meyer zum Büschenfelde; G. Gerken 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Effect of Low-Dose IL-2 Immunotherapy on

✍ Velilla, P.A.; Shata, M.T.; Lages, C.S.; Ying, J.; Fichtenbaum, C.J.; Chougnet, 📂 Article 📅 2008 🏛 Mary Ann Liebert 🌐 English ⚖ 348 KB

630 Baseline factors associated with hae

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 250 KB

P.1.197: HCV GENOTYPE 1 AND 4 TREATMENT

✍ F.R. Ponziani; S. Di Giambenedetto; M. Siciliano; B.E. Annicchiarico; M. Pompili 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Reduced-dose cladribine (2-CdA) plus mit

✍ M.J Rummel; K.U Chow; T Karakas; E Jäger; J Mezger; U von Grünhagen; K.-P Schalk 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 134 KB